| Year |
Citation |
Score |
| 2023 |
Blouin L, Sahel JA, Chung DC. Neurotrophic Factors in the Treatment of Inherited Retinal Diseases. Cold Spring Harbor Perspectives in Medicine. PMID 37848249 DOI: 10.1101/cshperspect.a041665 |
0.36 |
|
| 2022 |
Leroy BP, Fischer MD, Flannery JG, MacLaren RE, Dalkara D, Scholl HPN, Chung DC, Spera C, Viriato D, Banhazi J. Gene therapy for inherited retinal disease: long-term durability of effect. Ophthalmic Research. PMID 36103843 DOI: 10.1159/000526317 |
0.399 |
|
| 2022 |
Aleman TS, Huckfeldt RM, Serrano LW, Pearson DJ, Vergilio GK, McCague S, Marshall KA, Ashtari M, Doan TM, Weigel-DiFranco CA, Biron BS, Wen XH, Chung DC, Liu E, Ferenchak K, et al. AAV2-hCHM Subretinal Delivery to the Macula in Choroideremia: Two Year Interim Results of an Ongoing Phase I/II Gene Therapy Trial. Ophthalmology. PMID 35714735 DOI: 10.1016/j.ophtha.2022.06.006 |
0.496 |
|
| 2021 |
Maguire AM, Russell S, Chung DC, Yu ZF, Tillman A, Drack AV, Simonelli F, Leroy BP, Reape KZ, High KA, Bennett J. Durability of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease: Phase 3 Results at 3 Years and 4 Years. Ophthalmology. PMID 33798654 DOI: 10.1016/j.ophtha.2021.03.031 |
0.51 |
|
| 2019 |
Maguire AM, Russell S, Wellman JA, Chung DC, Yu ZF, Tillman A, Wittes J, Pappas J, Elci O, Marshall KA, McCague S, Reichert H, Davis M, Simonelli F, Leroy BP, et al. Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 Trials. Ophthalmology. 126: 1273-1285. PMID 31443789 DOI: 10.1016/J.Ophtha.2019.06.017 |
0.534 |
|
| 2018 |
Sochor MA, Vasireddy V, Drivas TG, Wojno A, Duong TT, Shpylchak I, Bennicelli J, Chung D, Bennett J, Lewis M. Author Correction: An Autogenously Regulated Expression System for Gene Therapeutic Ocular Applications. Scientific Reports. 8: 17286. PMID 30470797 DOI: 10.1038/S41598-018-35960-W |
0.419 |
|
| 2018 |
Chung DC, Bertelsen M, Lorenz B, Pennesi ME, Leroy BP, Hamel CP, Pierce E, Sallum J, Larsen M, Stieger K, Preising M, Weleber R, Yang P, Place E, Liu E, et al. The Natural History of Inherited Retinal Dystrophy due to Biallelic Mutations in the RPE65 Gene. American Journal of Ophthalmology. PMID 30268864 DOI: 10.1016/J.Ajo.2018.09.024 |
0.302 |
|
| 2017 |
Russell S, Bennett J, Wellman JA, Chung DC, Yu ZF, Tillman A, Wittes J, Pappas J, Elci O, McCague S, Cross D, Marshall KA, Walshire J, Kehoe TL, Reichert H, et al. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet (London, England). PMID 28712537 DOI: 10.1016/S0140-6736(17)31868-8 |
0.529 |
|
| 2017 |
Chung DC, McCague S, Yu ZF, Thill S, DiStefano-Pappas J, Bennett J, Cross D, Marshall K, Wellman J, High KA. Novel mobility test to assess functional vision in patients with inherited retinal dystrophies. Clinical & Experimental Ophthalmology. PMID 28697537 DOI: 10.1111/Ceo.13022 |
0.497 |
|
| 2016 |
Aleman TS, Han G, Serrano LW, Fuerst NM, Charlson ES, Pearson DJ, Chung DC, Traband A, Pan W, Ying GS, Bennett J, Maguire AM, Morgan JI. Natural History of the Central Structural Abnormalities in Choroideremia: A Prospective Cross-Sectional Study. Ophthalmology. PMID 27986385 DOI: 10.1016/J.Ophtha.2016.10.022 |
0.415 |
|
| 2016 |
Bennett J, Wellman J, Marshall KA, McCague S, Ashtari M, DiStefano-Pappas J, Elci OU, Chung DC, Sun J, Wright JF, Cross DR, Aravand P, Cyckowski LL, Bennicelli JL, Mingozzi F, et al. Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial. Lancet (London, England). PMID 27375040 DOI: 10.1016/S0140-6736(16)30371-3 |
0.548 |
|
| 2016 |
Garanto A, Chung DC, Duijkers L, Corral-Serrano JC, Messchaert M, Xiao R, Bennett J, Vandenberghe LH, Collin RW. In vitro and in vivo rescue of aberrant splicing in CEP290-associated LCA by antisense oligonucleotide delivery. Human Molecular Genetics. PMID 27106101 DOI: 10.1093/Hmg/Ddw118 |
0.501 |
|
| 2015 |
Sochor MA, Vasireddy V, Drivas TG, Wojno A, Doung T, Shpylchak I, Bennicelli J, Chung D, Bennett J, Lewis M. An Autogenously Regulated Expression System for Gene Therapeutic Ocular Applications. Scientific Reports. 5: 17105. PMID 26597678 DOI: 10.1038/Srep17105 |
0.495 |
|
| 2015 |
Vasireddy V, Mills JA, Gaddameedi R, Basner-Tschakarjan E, Kohnke M, Black AD, Alexandrov K, Zhou S, Maguire AM, Chung DC, Mac H, Sullivan L, Gadue P, Bennicelli JL, French DL, et al. Correction: AAV-Mediated Gene Therapy for Choroideremia: Preclinical Studies in Personalized Models. Plos One. 10: e0129982. PMID 26090960 DOI: 10.1371/Journal.Pone.0129982 |
0.475 |
|
| 2014 |
Morgan JI, Han G, Klinman E, Maguire WM, Chung DC, Maguire AM, Bennett J. High-resolution adaptive optics retinal imaging of cellular structure in choroideremia. Investigative Ophthalmology & Visual Science. 55: 6381-97. PMID 25190651 DOI: 10.1167/Iovs.13-13454 |
0.434 |
|
| 2014 |
Black A, Vasireddy V, Chung DC, Maguire AM, Gaddameedi R, Tolmachova T, Seabra M, Bennett J. Adeno-associated virus 8-mediated gene therapy for choroideremia: preclinical studies in in vitro and in vivo models. The Journal of Gene Medicine. 16: 122-30. PMID 24962736 DOI: 10.1002/Jgm.2768 |
0.564 |
|
| 2014 |
Canver MC, Canver AC, Revere KE, Amado D, Bennett J, Chung DC. Novel mathematical algorithm for pupillometric data analysis. Computer Methods and Programs in Biomedicine. 113: 221-5. PMID 24129048 DOI: 10.1016/J.Cmpb.2013.08.008 |
0.439 |
|
| 2013 |
Vasireddy V, Mills JA, Gaddameedi R, Basner-Tschakarjan E, Kohnke M, Black AD, Alexandrov K, Zhou S, Maguire AM, Chung DC, Mac H, Sullivan L, Gadue P, Bennicelli JL, French DL, et al. AAV-mediated gene therapy for choroideremia: preclinical studies in personalized models. Plos One. 8: e61396. PMID 23667438 DOI: 10.1371/Journal.Pone.0061396 |
0.575 |
|
| 2012 |
Cronin T, Chung DC, Yang Y, Nandrot EF, Bennett J. The Signalling Role of the avβ5-Integrin Can Impact the Efficacy of AAV in Retinal Gene Therapy. Pharmaceuticals (Basel, Switzerland). 5: 447-59. PMID 24281556 DOI: 10.3390/Ph5050447 |
0.551 |
|
| 2012 |
Bennett J, Chung DC, Maguire A. Gene delivery to the retina: from mouse to man. Methods in Enzymology. 507: 255-74. PMID 22365778 DOI: 10.1016/B978-0-12-386509-0.00013-2 |
0.563 |
|
| 2012 |
Bennett J, Ashtari M, Wellman J, Marshall KA, Cyckowski LL, Chung DC, McCague S, Pierce EA, Chen Y, Bennicelli JL, Zhu X, Ying GS, Sun J, Wright JF, Auricchio A, et al. AAV2 gene therapy readministration in three adults with congenital blindness. Science Translational Medicine. 4: 120ra15. PMID 22323828 DOI: 10.1126/scitranslmed.3002865 |
0.557 |
|
| 2011 |
Chung DC, Fogelgren B, Park KM, Heidenberg J, Zuo X, Huang L, Bennett J, Lipschutz JH. Adeno-Associated Virus-Mediated Gene Transfer to Renal Tubule Cells via a Retrograde Ureteral Approach. Nephron Extra. 1: 217-23. PMID 22470395 DOI: 10.1159/000333071 |
0.468 |
|
| 2011 |
Ashtari M, Cyckowski LL, Monroe JF, Marshall KA, Chung DC, Auricchio A, Simonelli F, Leroy BP, Maguire AM, Shindler KS, Bennett J. The human visual cortex responds to gene therapy-mediated recovery of retinal function. The Journal of Clinical Investigation. 121: 2160-8. PMID 21606598 DOI: 10.1172/Jci57377 |
0.542 |
|
| 2009 |
Maguire AM, High KA, Auricchio A, Wright JF, Pierce EA, Testa F, Mingozzi F, Bennicelli JL, Ying GS, Rossi S, Fulton A, Marshall KA, Banfi S, Chung DC, Morgan JI, et al. Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial. Lancet. 374: 1597-605. PMID 19854499 DOI: 10.1016/S0140-6736(09)61836-5 |
0.566 |
|
| 2009 |
Revere KE, Chung DC. Recent breakthroughs in gene therapy for inherited retinal degeneration. Discovery Medicine. 8: 125-9. PMID 19833058 |
0.435 |
|
| 2009 |
Chung DC, Lee V, Maguire AM. Recent advances in ocular gene therapy. Current Opinion in Ophthalmology. 20: 377-81. PMID 19667988 DOI: 10.1097/ICU.0b013e32832f802a |
0.328 |
|
| 2008 |
Bennicelli J, Wright JF, Komaromy A, Jacobs JB, Hauck B, Zelenaia O, Mingozzi F, Hui D, Chung D, Rex TS, Wei Z, Qu G, Zhou S, Zeiss C, Arruda VR, et al. Reversal of blindness in animal models of leber congenital amaurosis using optimized AAV2-mediated gene transfer. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 458-65. PMID 18209734 DOI: 10.1038/Sj.Mt.6300389 |
0.528 |
|
| 2007 |
Endo M, Zoltick PW, Chung DC, Bennett J, Radu A, Muvarak N, Flake AW. Gene transfer to ocular stem cells by early gestational intraamniotic injection of lentiviral vector. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 579-87. PMID 17245352 DOI: 10.1038/sj.mt.6300092 |
0.489 |
|
| 2004 |
Wong WT, Rex TS, Auricchio A, Maguire AM, Chung D, Tang W, Bennett J. Effect of over-expression of pigment epithelium derived factor (PEDF) on developing retinal vasculature in the mouse. Molecular Vision. 10: 837-44. PMID 15547489 |
0.513 |
|
| Show low-probability matches. |